Medical Countermeasures New Mutation and DNA Repeats Behind Ceftazidime Resistance in Melioidosis BacteriumGlobal Biodefense StaffSeptember 5, 2025
Medical Countermeasures Appili Therapeutics Reports Strong Preclinical Protection from ATI-1701 Tularemia VaccineGlobal Biodefense StaffAugust 11, 2025
Medical Countermeasures Pan-Coronavirus Drug Discovery Gets a Boost from Global AI Blind ChallengeGlobal Biodefense StaffJuly 28, 2025
New Tuberculosis Drug Regimen Will Move to Landmark Phase 3 Trial Antimicrobial Resistance April 28, 2014 …
Rutgers Awarded $26M to Lead Development of New Antibiotics Antimicrobial Resistance April 28, 2014 …
Novel Agent for Tamiflu-Resistant pH1N1 Influenza Virus Discovered Medical Countermeasures April 24, 2014 …
Researchers Discover Possible New Target to Attack Flu Virus Medical Countermeasures April 13, 2014 …
Notable Contracts: DTRA Small Molecule Countermeasures Research Medical Countermeasures April 10, 2014 …
Rapid, Broad Countermeasures Sought Against Mystery Infections Medical Countermeasures April 8, 2014 …
Pharmocogenomics Has Not Fulfilled Its Promise to Developing Countries Medical Countermeasures April 4, 2014 …
UGA Awarded Grand Challenges Funding for Rotavirus Vaccine Research Medical Countermeasures April 1, 2014 …
USAMRIID Seeks Animal Vaccination Services for Immunogenicity Studies Contracts + Grants March 31, 2014 …
Bacterial Reporters Pave the Way to Living Diagnostics and Therapeutics Medical Countermeasures March 28, 2014 …
